Our Mission
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit, multidisciplinary, professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy.
Latest News
-
16 May 2025ISHLT Foundation Funds Research in AI + Biomarkers in Heart and Lung Transplantation, and ECP
-
15 May 2025Thoracic Transplantation Around the Globe: An ISHLT2025 Registry Special Session Recap
-
14 May 2025Daniel Goldstein, Leader in Cardiothoracic Surgery and MCS, Honored by ISHLT
ISHLT now has an online store where you can purchase merch! Visit the ISHLT Store and check out the featured products, incljuding special ISHLT2024 items.
Shop the ISHLT Store
ISHLTconnect is an online discussion platform open to anyone involved in the management and treatment of advanced heart and lung disease, transplantation, mechanical circulatory support, and pulmonary vascular disease. Members get complete access to all interdisciplinary discussion groups, while nonmembers can explore ten Professional Community boards.
Log InUpcoming Events
-
21 May, 2025 4:00 p.m. to 5:00 p.m. EDT2025 Annual Business Meeting
Save the date for the 2025 ISHLT Annual Business Meeting. No registration is required, but attendance is restricted to ISHLT Members only. -
29 May, 2025 9:00 a.m. to 10:00 a.m. EDTNavigating Heart Failure Therapy: Pre-AHFT Considerations for Cancer Survivors
ISHLT/IC-OS Joint Webinar
This expert-led session explores heart failure therapy planning for cancer survivors. It focuses on cardio-oncology considerations before initiating advanced heart failure treatment. Join us as faculty discuss risk assessment, treatment selection and multidisciplinary coordination in this high-risk population. -
4 to 5 June, 20252025 Karolinska Cardiogenic Shock Days
The 2025 Karolinska Cardiogenic Shock Days will bring international leading experts together to discuss the challenges and latest advancements in cardiogenic shock.Stockholm, Sweden
and Lung Transplantation
